FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs
The FDA has approved lutetium Lu 177 dotatate for pediatric patients 12 years of age and older with SSTR–positive GEP-NETs.
Source: onclive.com
Gep Nets News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gep Nets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gep Nets Today - Breaking & Trending Today
177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs
Lutetium Lu 177 dotatate plus octreotide significantly improved PFS vs high-dose octreotide in patients with gastroenteropancreatic neuroendocrine tumors.
Source: onclive.com
FDA Accepts Filing of Abbreviated NDA for Generic Lutathera in GEP-NETs
The FDA has accepted the filing of an abbreviated new drug application (ANDA) for Lutetium Lu 177 Dotatate, a generic version of lutetium Lu 177 dotatate indicated for the treatment of patients with somatostatin receptor–positive gastroenteropancreatic neuroendocrine tumors, including foregut, midgut, and hindgut neuroendocrine tumors in adults.
Source: onclive.com
ITM to Present Phase III COMPOSE Poster and Host Satellite
Garching / Munich, March 16, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical theranostics company, today announced that the...
Source: globenewswire.com